Non Small Cell Lung Cancer — Study of Selumetinib in Patients With Previously Treated or Untreated Advanced/Metastatic NSCLC
Citation(s)
A Phase Ib Study of Selumetinib in Patients With Previously Treated or Untreated Advanced/Metastatic NSCLC Who Are Receiving Standard Chemotherapy Regimens.